Fusidic acid in skin and soft tissue infections

International Journal of Antimicrobial Agents

Volumn 12, Issue SUPPL. 2, 1999, Pages

  Spelman, Denis ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Fusidic acid; Soft tissue; Staphylococcus aureus; Streptococcus pyogenes

Indexed keywords

ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; HYDROGEN PEROXIDE; POLYMYXIN; PRISTINAMYCIN; PSEUDOMONIC ACID; TRIMETHOPRIM;

ABSCESS; ACNE; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 0032838434     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00074-0     Document Type: Article

References (65)

1. Vaillant L, Machet L, Taburet AM, Sorensen H, Lorette G Levels of fusidic acid in skin blister fluid and serum after repeated administration of two doses (250 and 500 mg). Br J Dermatol. 126:1992;591-595.
2. Pagan FS Antibiotics for Gram-positive organisms. Br J Hosp Med. 25:1981;24-27.
3. Carr WD, Wall AR, Georgala-Zervogiani S, Stratigos J, Gouriotou K Fusidic acid tablets in patients with skin and soft-tissue infection: a dose-finding study. Eur J Clin Res. 5:1994;87-95.
4. Kucers A Fusidate sodium. Kucers A, Crowe SM, Grayson ML, Hoy JF The Use of Antibiotics. 5th edition:1997;580-586 Butterworth Heinemann, Oxford.
5. Dineen P Fusidate sodium in treatment of surgical infections. Arch Surg. 96:1968;219-221.
6. Porter IA, Wilson JS Staphylococcal infections treated with fusidic acid in nurses. Lancet. 2:1963;658-659.
7. Schumer W, Abtahi H Sodium fusidate in surgical wound infections. Am J Surg. 115:1968;527-530.
8. Nordin P, Mobacken H. A comparison of fusidic acid and flucloxacillin in the treatment of skin and soft-tissue infection. Eur J Clin Res 1994;5:97-106.
9. Machet L, Puissant A, Vaillant L, Amblard P, Body S, Bonerandi JJ, Bonnetblanc JM, Bozzetto G, Claudy A., Combemale P., Conil J.G., Delanoe J., Forestier J.F., Grognard C., Grossetete, Guidoni J.F., Guilhou J.J., Guillot B., Le Marchand D. Treatment of skin infections with two dosages of fusidic acid (500 mg/day and 1 g/day) compared with pristinamycin 2 g/day: a multicenter randomised study. Nouv Dermatol. 13:1994;520-524.
10. Garborg O., Nyjordet R. Pyogenic cutaneous infections in East African children treated with fusidic acid ointment. J Trop Pediatr Environ Child Health. 17:1971;153-157.
11. Johnston C., Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol. 24:1991;797-799.
12. Morley P.A.R., Munot L.D. A comparison of fusidic acid ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin. 11:1988;142-148.
13. White D.G., Collins P.O., Rowsell R.B. Topical antibiotics in the treatment of superficial skin infections in general practice: a comparison of mupirocin with fusidic acid. J Infect. 18:1989;221-229.
14. Ohman S.C., Jontell M. Treatment of angular cheilitis: the significance of microbial analysis, antimicrobial treatment and interfering factors. Acta Odontol Scand. 46:1988;267-272.
15. Somerville D.A., Noble W.C., White P.M., Seville R.H., Savin J.A. Fusidic acid in the treatment of erythrasma. Br J Dermatol. 85:1971;450-453.
16. Baldwin R.J.T., Cranfield R. A multi-centre general practice trial comparing fusidic acid ointment and fusidic acid cream. Br J Clin Pract. 35:1981;157-160.
17. Cassels-Brown G. A comparative study of fusidic acid ointment and cicatrin cream in the treatment of impetigo. Br J Clin Pract. 35:1981;153-155.
18. Pakrooh H. Comparative trial of fusidic acid ointment and fusidic acid cream in skin sepsis. J Int Med Res. 8:1980;425-429.
19. Wilkinson J.D., Leigh D.A. Comparative efficacy of betamethasone and either fusidic acid or neomycin in infected or potentially infected eczema. Curr Ther Res Clin Exp. 38:1985;177-182.
20. Sutton J.B., Langdon C.G. An analysis of the cost effectiveness of fusidic acid cream and mupirocin ointment in the treatment of supefficial skin sepsis in general practice. Br J Med Econ. 6:1993;37-43.
21. Christensen O.B., Anehus S. Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm-Venereol. 74:1994;460-462.
22. Petersen C.S., Thomsen K. Fusidic acid cream in the treatment of plasma cell balanitis. J Am Acad Dermatol. 27:1992;633-634.
23. Jaafar R.B., Pettit J.H., Gibson J.R., Harvey S.G., Marks P., Webster A. Trimethoprimpolymyxin B sulfate cream versus fusidic acid cream in the treatment of pyodermas. Int J Dermatol. 26:1987;60-63.
24. Jaafar R.B., Pettit J.H., Lumpur K., Gibson J.R., Harvey S.G., Marks P. Trimethoprimpolymyxin B sulfate cream versus fusidic acid cream in the treatment of pyodermas: an update (letter). Int J Dermatol. 30:1991;746.
25. el Mofty M., Harvey S.G., Gibson J.R., Calthrop J.G., Marks P. Trimethoprim-polymyxin B sulphate cream compared with fusidic acid cream in the treatment of superficial bacterial infection of the skin. J Int Med Res. 18:1990;89-93.
26. Hansted B., Jorgensen J., Reymann F., Christiansen J. Fusidic acid (TM) cream for topical treatment of acne vulgaris. Curr Ther Res Clin Exp. 37:1985;249-253.
27. Ritchie I.C. Technique to improve the rate of healing of incised abscesses. Br Med J. 2:1972;381-383.
28. Courtney S.P., Merlin M.J. The use of fusidic acid gel in pilonidal abscess treatment: cure, recurrence, and failure rates. Ann R Coll Surg Engl. 68:1986;170-171.
29. Kotowski J. Treatment of axillary abscesses with fusidic acid gel. Practitioner. 222:1979;269-271.
30. Franklin A., Calver R.F. Packing of abscess cavities. Lancet. 2:1973;573-574.
31. Franklin A., Calver R.F. Fusidic acid gel in the treatment of abscesses. Practitioner. 212:1974;388-390.
32. McCormack B.L., Nathan M.S., Fernandez A. Practical evaluation of a new fusidic acid (fusidic acid) wound dressing. J Ir Med Assoc. 61:1968;137-141.
33. Johansen A.M., Sorensen B. Treatment of donor sites: a controlled trial with fusidic acid ganze. Scand J Plast Reconstr Surg. 6:1972;47-50.
34. De Boer P., Collinson P.O. The use of silver sulphadiazine occlusive dressings for finger-tip injuries. J Bone Jt Surg (Edinburgh). 63:1981;545-547.
35. Ritchie I.C. Packing of abscess cavities (letter). Lancet. 2:1973;1211.
36. Adams J., Thorn P. Topical fusidic acid versus peroral doxycycline in the treatment of patients with acne vulgaris of the face. Curr Ther Res Clin Exp. 50:1991;268-273.
37. Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol. 20:1989;1083-1087.
38. Morley PAR, Munot LD A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Res Med Opinion. 11:1988;142-148.
39. Langdon CG, Mahaputra KS Efficacy and acceptability of fusidic acid cream and mupirocin ointment in acute skin sepsis. Curr Ther Res. 48:1990;174-180.
40. Sutton JB Efficacy and acceptability of fusidic acid cream and mupirocin ointment in acute skin sepsis. Curr Ther Res. 51:1992;673-678.
41. Marras F. Therapeutic usefulness of a corticosteroid antibacterial and antifungal combination in skin diseases of various origins. Pharmatherapeutica. 4:1985;8891.
42. Carbone F. Combination of an anti-inflammatory steroid, an antibacterial agent and an antifungal agent: a study in a specialist dermatology department. Clin Trials J. 22:1985;158-164.
43. Cogo R. Treatment of dermatological conditions of mixed aetiology by topical application of a combination of anti-inflammatory steroid, an antibacterial agent and an antifungal agent. Clin Trials J. 22:1985;79-83.
44. Cristiani T. Therapeutic results of a combination of an anti-inflammatory steroid, an antibacterial agent and an antifungal agent in dermatoses of various aetiology. Clin Trials J. 22:1985;179-186.
45. Mentasti G., Caraffa M., Bonvini E. Treatment of skin lesions in children with a combination of a corticosteroid, an antibacterial and an antifungal agent. Clin Trials J. 22:1985;142-148.
46. Reali D. Treatment of dermatological conditions of mixed aetiology: combination of an anti-inflammatory, an antibacterial and an antifungal agent. Clin Trials J. 22:1985;814.
47. Berardesca E. Combination treatment of skin diseases of mixed aetiology with an anti-inflammatory steroid an antibacterial agent, and an antifungal. Curr Ther Res Clin Exp. 37:1985;791-796.
48. Cristiani T. Experience with the combination of an anti-inflammatory steroid, an antibacterial agent and an antimycotic agent in the topical treatment of skin diseases of various origins. Curr Ther Res Clin Exp. 37:1985;225-231.
49. Donadini A. The combination of an anti-inflammatory steroid an antibacterial agent, and an antifungal in the treatment of outpatients with skin disease of uncertain aetiology. Curr Ther Res Clin Exp. 37:1985;478-484.
50. Donadini A., Berardesca E. Clinical trial with an extempore combination of fusidic acid, ketoconazole and clobetasone butyrate in the treatment of a variety of skin diseases. Curr Ther Res Clin Exp. 37:1985;241-248.
51. Minak G. Jr., Beverini S. Treatment of forms of infantile dermatitis with a multipurpose drug combination. Curr Ther Res Clin Exp. 36:1984;1198-1202.
52. Trabacco M. Treatment of dermatological manifestations in infants with a multivalent combination. Curr Ther Res Clin Exp. 37:1985;784-790.
53. Bianchi G. Multivalent treatment of skin diseases in infants and young children. Drugs Exp Clin Res. 11:1985;819-822.
54. Franchi G. Treatment of dermatological conditions with a combination of an antibacterial agent, an antifungal agent and an antiinflammatory steroid. Int J Clin Pharmacol Ther Toxicol. 23:1985;488-490.
55. Gini M. Use of a combination of an anti-inflammatory corticosteroid, an antibacterial agent and an antifungal in the local post-operative treatment of cutaneo-mucosal diseases following cryosurgery. Int J Clin Pharmacol Ther Toxicol. 23:1985;373-375.
56. Pellerano S. Use of a combination of an anti-inflammatory steroid, an antibacterial agent and an antifungal in dermatological practice. Int J Clin Pharmacol Ther Toxicol. 23:1985;215-218.
57. Pazzaglia A. Therapeutic effects and tolerance of an extempore combination of an antibacterial, an anti-inflammatory, and an antimycotic cream in skin diseases of various origins. Pharmatherapeutica. 4:1985;122-125.
58. Scremin S. Treatment of skin diseases of various origins with a multi-action drug combination. Pharmatherapeutica. 4:1985;296-299.
59. Hamann K., Thorn P. Systemic or local treatment of erythrasma: a comparison between erythromycin tablets and fusidic acid (TM) cream in general practice. Scand J Prim Health Care. 9:1991;35-39.
60. Macmillan A.L., Sarkany I. Specific topical therapy for erythrasma. Br J Dermatol. 82:1970;507-509.
61. Brakenbury P.H., Ratnam J.S. Comparison of two methods of treating acute abscesses. Practitioner. 229:1985;73-78.
62. Wong H.B. The child with recurrent boils. J Singap Paediatr Soc. 30:1988;25-30.
63. Hedstrom S.A. Treatment and prevention of recurrent staphylococcal furunculosis: clinical and bacteriological followup. Scand J Infect Dis. 17:1985;55-58.
64. Commens C., Swarbrick P.T. Infections of the skin with Staphylococcus aureus. Mod Med Aust. 36:1993;74-80.
65. Taylor PB, Tabbara KF, Burd EM Effect of preoperative fusidic acid on the normal eyelid and conjunctival bacterial flora. Br J Ophthalmol. 72:1988;206-209.